Cellmid Ltd
ASX:CDY

Watchlist Manager
Cellmid Ltd Logo
Cellmid Ltd
ASX:CDY
Watchlist
Price: 0.054 AUD 8% Market Closed
Market Cap: AU$11.9m

Operating Margin

-68.9%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-68.9%
=
Operating Income
AU$-4m
/
Revenue
AU$5.8m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-68.9%
=
Operating Income
AU$-4m
/
Revenue
AU$5.8m

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Cellmid Ltd
ASX:CDY
10.9m AUD
Loading...
FR
L'Oreal SA
PAR:OR
204.3B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
118.8B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
Loading...
UK
HALEON PLC
LSE:HLN
33.8B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
42.4B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.2B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
920.5B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

In line with most companies in Australia
Percentile
44th
Based on 3 951 companies
44th percentile
-68.9%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Cellmid Ltd
Glance View

Market Cap
11.9m AUD
Industry
Consumer products

Cellmid Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-12-09. The firm is specialized in developing anti-aging solutions. The firm operates through two segments: Diagnostics and Consumer Health. The firm is engaged in the research and development of diagnostic and therapeutic products for the management of diseases, such as cancer and various chronic inflammatory conditions by targeting midkine. The company is also engaged in the development and sale of over the counter (OTC) and cosmetic products for hair loss and anti-aging hair care through its FGF5 inhibitor technology. The company has developed a range of products under the evolis, evolis Professional, Lexilis Hybrid, Jo-JuRED and Lexilis BLACK brands.

CDY Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-68.9%
=
Operating Income
AU$-4m
/
Revenue
AU$5.8m
How has Operating Margin changed over time?

Over the last 3 years, Cellmid Ltd’s Operating Margin has increased from -75.2% to -68.9%. During this period, it reached a low of -106.1% on Dec 31, 2018 and a high of -26.9% on Dec 31, 2019.

Back to Top